BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 3276724)

  • 1. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R
    J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA.
    Tolosa E; Roura C; Catálfamo M; Martí M; Lucas-Martín A; Sanmartí A; Salinas I; Obiols G; Foz-Sala M; Pujol-Borrell R
    J Autoimmun; 1992 Feb; 5(1):107-18. PubMed ID: 1348415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathological findings and thyroid autoantibodies in thyroid autonomy.
    Bretzel RG; Platzer A; Schaeffer R
    Acta Med Austriaca; 1990; 17 Suppl 1():20-4. PubMed ID: 2202177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumors.
    Goldsmith NK; Dikman S; Bermas B; Davies TF; Roman SH
    Clin Immunol Immunopathol; 1988 Aug; 48(2):161-73. PubMed ID: 3390969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
    J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathyroidal dendritic cells.
    Kabel PJ; Voorbij HA; De Haan M; van der Gaag RD; Drexhage HA
    J Clin Endocrinol Metab; 1988 Jan; 66(1):199-207. PubMed ID: 3335603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of intercellular adhesion molecule-1 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer.
    Bagnasco M; Caretto A; Olive D; Pedini B; Canonica GW; Betterle C
    Clin Exp Immunol; 1991 Feb; 83(2):309-13. PubMed ID: 1671565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic expression of HLA class II antigens on thyroid follicular cells: induction and transfer in vitro by autologous mononuclear leukocytes.
    Khoury EL; Greenspan JS; Greenspan FS
    J Clin Endocrinol Metab; 1988 Nov; 67(5):992-1004. PubMed ID: 2972740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
    Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
    Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas.
    Renné C; Ramos Lopez E; Steimle-Grauer SA; Ziolkowski P; Pani MA; Luther C; Holzer K; Encke A; Wahl RA; Bechstein WO; Usadel KH; Hansmann ML; Badenhoop K
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5810-4. PubMed ID: 15531546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.
    Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune thyroid disease--a perspective.
    Volpé R
    Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
    Jansson R; Karlsson A; Forsum U
    Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
    Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
    J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engraftment of human lymphocytes and thyroid tissue into scid and rag2-deficient mice: absent progression of lymphocytic infiltration.
    Martin A; Valentine M; Unger P; Yeung SW; Shultz LD; Davies TF
    J Clin Endocrinol Metab; 1994 Sep; 79(3):716-23. PubMed ID: 8077352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: an immunohistological study.
    Misaki T; Konishi J; Arai K; Iida Y; Kasagi K; Kuma K; Torizuka K
    Endocrinol Jpn; 1987 Apr; 34(2):257-62. PubMed ID: 3113922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)].
    Ikekubo K
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):840-55. PubMed ID: 1243915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
    Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.